Theseus Pharmaceuticals I...

NASDAQ: THRX · Real-Time Price · USD
4.07
0.01 (0.25%)
At close: Feb 13, 2024, 9:59 PM

Theseus Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Net Income
-50.61M -27.31M
Depreciation & Amortization
50K 2K
Stock-Based Compensation
11.41M 4.36M
Other Working Capital
2.58M -4.1M
Other Non-Cash Items
-350K 4.36M
Deferred Income Tax
n/a -4.36M
Change in Working Capital
6.55M -4.25M
Operating Cash Flow
-32.95M -27.19M
Capital Expenditures
-455K 12K
Cash Acquisitions
116.84K n/a
Purchase of Investments
-191.44M n/a
Sales Maturities Of Investments
74.6M n/a
Other Investing Acitivies
-116.84K n/a
Investing Cash Flow
-117.29M 12K
Debt Repayment
n/a n/a
Common Stock Repurchased
n/a n/a
Dividend Paid
n/a n/a
Other Financial Acitivies
182K 263.78M
Financial Cash Flow
182.00 263.78M
Net Cash Flow
-150.06M 236.58M
Free Cash Flow
-33.4M -27.18M